Search NLS News

Jay Detsky, radiation oncologist at Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada, has presented initial cancer control outcomes from the UNITED trial (Unity-Based MR-Linac Guided Adaptive Radiotherapy for High Grade Glioma).

Emelie Antoni has nearly 25 years of experience from the pharmaceutical industry and from several leadership roles abroad.

At first glance, science and art seem worlds apart. The quality of a scientific study is determined byevidence, facts, reproducibility, and accuracy, while the quality of a piece of art is determined by its viewer, notwithstanding its originality and the artist’s talent to paint or sculpt. Art is subjective and is often based on emotions and opinions. 

Cereno Scientific has signed an agreement with medical technology company Fluidda on Respiratory Imaging solutions, with the aim to visualize signs of reverse remodeling of lead drug candidate CS1 in Pulmonary Arterial Hypertension (PAH) in a clinical setting.

Evaxion Biotech has entered into an option and license agreement with MSD for two preclinical vaccine candidates.

The 11th edition of NLSDays was held at Malmömässan in Malmö on September 18-19. Nordic Life Science was there to cover, report and give you some of the highlights.

Ribocure Pharmaceuticals and Suzhou Ribo Life Science have entered a partnership with Pheiron to leverage its AI platform in Ribo’s discovery and development of RNA-based therapeutics.

FluMist, a needle-free nasal spray, was approved to be self-administered by adults up to 49 years of age or administered by a parent/caregiver to individuals 2-17 years of age.

OnDosis, Tiefenbacher Group and Star's digital product Oysta Digital Service has been awarded the UX Design Awards Design Award in the Product category.

Urban Eriksson has been appointed as the new Chairman of the board for Umeå Biotech Incubator.